Seelos Therapeutics
Patents, Design & Utilities

Last updated:

List of all Seelos Therapeutics patents 7 in total

Status Patent
Application
Utility: TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE External link
Filling date: 26 Sep 2025 Issue date: 21 Apr 2022
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER External link
Filling date: 26 Sep 2025 Issue date: 14 Jan 2021
Grant
Utility: Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose External link
Filling date: 26 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: Compositions and methods for treating an aggregation disease or disorder External link
Filling date: 26 Sep 2025 Issue date: 25 Aug 2020
Application
Utility: TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE External link
Filling date: 26 Sep 2025 Issue date: 12 Dec 2019
Grant
Utility: Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose External link
Filling date: 26 Sep 2025 Issue date: 3 Dec 2019
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER External link
Filling date: 26 Sep 2025 Issue date: 7 Nov 2019

Showing 1 to 7 of 7 patents.